Brief: Galera Announces Final Results From Pancreatic Cancer Trial Showing Improvements On All Efficacy Parameters
Sept 8 (Reuters) - Galera Therapeutics Inc GRTX.O :
* GALERA ANNOUNCES FINAL RESULTS FROM PANCREATIC CANCER
TRIAL
SHOWING IMPROVEMENTS ON ALL EFFICACY PARAMETERS
* GALERA THERAPEUTICS INC - HAZARD RATIOS BETTER THAN 0.5 ON
ALL
SURVIVAL AND TUMOR OUTCOME ENDPOINTS
* GALERA THERAPEUTICS INC - COMBINATION WITH SBRT WAS WELL
TOLERATED IN ACTIVE AND PLACEBO ARMS
Source text for Eikon: ID:nGNXHPtxH
Further company coverage: GRTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Obsidian Therapeutics
See all newsBrief: Obsidian Therapeutics - Files Prospectus Relates To Resale Of Up To 29,164,045 Shares Of Common Stock By Selling Stockholders- SEC Filing
NASDAQ RESUMED AT 09:40 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:31 AM
NASDAQ RESUMED AT 11:05 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:00 AM